Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 04, 2022

SELL
$161.19 - $257.96 $160,222 - $256,412
-994 Closed
0 $0
Q3 2021

Nov 05, 2021

BUY
$194.77 - $324.21 $193,601 - $322,264
994 New
994 $287,000
Q1 2021

May 12, 2021

SELL
$180.37 - $226.26 $211,032 - $264,724
-1,170 Closed
0 $0
Q4 2020

Feb 05, 2021

SELL
$148.08 - $206.57 $11,698 - $16,319
-79 Reduced 6.33%
1,170 $224,000
Q3 2020

Oct 16, 2020

SELL
$122.51 - $158.27 $12,373 - $15,985
-101 Reduced 7.48%
1,249 $184,000
Q2 2019

Jul 31, 2019

BUY
$54.2 - $85.95 $73,170 - $116,032
1,350 New
1,350 $116,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Ropes Wealth Advisors LLC Portfolio

Follow Ropes Wealth Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ropes Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ropes Wealth Advisors LLC with notifications on news.